Cargando…

Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid

Detalles Bibliográficos
Autores principales: Ma, Chunhua, Huang, Chuoji, Tang, Dongjiang, Ye, Xin, Li, Zhi, Liu, Renzhong, Mu, Ning, Li, Jing, Jiang, Rong, Zhang, Juncheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798028/
https://www.ncbi.nlm.nih.gov/pubmed/31641649
http://dx.doi.org/10.3389/fonc.2019.00938
_version_ 1783459956878475264
author Ma, Chunhua
Huang, Chuoji
Tang, Dongjiang
Ye, Xin
Li, Zhi
Liu, Renzhong
Mu, Ning
Li, Jing
Jiang, Rong
Zhang, Juncheng
author_facet Ma, Chunhua
Huang, Chuoji
Tang, Dongjiang
Ye, Xin
Li, Zhi
Liu, Renzhong
Mu, Ning
Li, Jing
Jiang, Rong
Zhang, Juncheng
author_sort Ma, Chunhua
collection PubMed
description
format Online
Article
Text
id pubmed-6798028
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67980282019-10-22 Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid Ma, Chunhua Huang, Chuoji Tang, Dongjiang Ye, Xin Li, Zhi Liu, Renzhong Mu, Ning Li, Jing Jiang, Rong Zhang, Juncheng Front Oncol Oncology Frontiers Media S.A. 2019-09-25 /pmc/articles/PMC6798028/ /pubmed/31641649 http://dx.doi.org/10.3389/fonc.2019.00938 Text en Copyright © 2019 Ma, Huang, Tang, Ye, Li, Liu, Mu, Li, Jiang and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ma, Chunhua
Huang, Chuoji
Tang, Dongjiang
Ye, Xin
Li, Zhi
Liu, Renzhong
Mu, Ning
Li, Jing
Jiang, Rong
Zhang, Juncheng
Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid
title Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid
title_full Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid
title_fullStr Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid
title_full_unstemmed Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid
title_short Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid
title_sort corrigendum: afatinib for advanced non-small cell lung cancer in a case with an uncommon epidermal growth factor receptor mutation (g719a) identified in the cerebrospinal fluid
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798028/
https://www.ncbi.nlm.nih.gov/pubmed/31641649
http://dx.doi.org/10.3389/fonc.2019.00938
work_keys_str_mv AT machunhua corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT huangchuoji corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT tangdongjiang corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT yexin corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT lizhi corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT liurenzhong corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT muning corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT lijing corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT jiangrong corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid
AT zhangjuncheng corrigendumafatinibforadvancednonsmallcelllungcancerinacasewithanuncommonepidermalgrowthfactorreceptormutationg719aidentifiedinthecerebrospinalfluid